Core Insights - The company is facing challenges in its oral business due to product iteration and increasing market competition, leading to smaller revenue scale [1] - A new generation of high-end bone integration implants and accessories has been approved and is gradually being launched to enhance competitiveness in the oral sector [1] - The company is diversifying its product offerings in the oral field through external investments in oral tissue repair products [1] Group 1 - The company is actively expanding its business into thoracic surgery, oral surgery, maxillofacial repair, and skin filling, aiming for stable growth through diversification [1] - The company has developed a PEEK material injection molding process and additive manufacturing technology platform, becoming the only known supplier of a full PEEK material solution for cranial repair fixation [1][2] - The PEEK 4D bioactive plates produced using additive manufacturing enhance cell adhesion and proliferation, improving postoperative experiences for patients [2] Group 2 - The company is accelerating its global expansion, with sales covering over 30 countries, and is focusing on enhancing operational efficiency [2] - A localization project for PEEK bone plates is being implemented in the U.S. market to improve supply chain responsiveness and support overseas business growth [2]

证券代码：300206 证券简称：理邦仪器 编号：2025-001 深圳市理邦精密仪器股份有限公司 投资者关系活动记录表 | 投资者关 | □特定对象调研 □分析师会议 | | --- | --- | | 系活动类 | □媒体采访 ■业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | □现场参观 □其他 | | | 东吴证券、西南证券、太平洋证券、天风证券、国盛证券、中金资管、领颐资产、 华夏基金、明汯投资、广发基金、博远基金、蜂巢基金、益和源投资、创金合信、 | | 参与单位 | 中信期货、汇丰晋信基金、上海证券资管、易鑫安、上海天猊投资、颐和久富、 | | 名称及人 | | | 员姓名 | 深圳市正德泰投资、安信基金、华安基金、上海尚雅投资、申万菱信、前海天成 | | | 时代、中融基金、华杉投资、鑫诺嘉誉投资、大家资产管理、北京金百镕投资、 | | | 锦洋资产、西部证券、广东泓骐基金、国金证券 | | 时间 | 2025 年 4 月 24 日 15:00-16:00 | | 地点 | 公司董事会议室 | | 上市公司 | 董事长：张浩 | | 接待人员 | 董事会秘书：祖幼冬 | | 姓 ...